Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Extensive and severe CNS demyelination associated with golimumab therapy.
Epidermal growth factor preserves myelin and promotes astrogliosis after intraventricular hemorrhage.
Microglia: Senescence Impairs Clearance of Myelin Debris.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Hospital admission rates for pediatric multiple sclerosis in the United States using the Pediatric Health Information System (PHIS).
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
The Sphingosine-1-phosphate Analogue, FTY -720, Promotes the Proliferation of Embryonic Neural Stem Cells, Enhances Hippocampal Neurogenesis and Learning and Memory Abilities in Adult Mice.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
Contribution of EAE to understanding and treating multiple sclerosis.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
CLARITY-compatible lipophilic dyes for electrode marking and neuronal tracing.
Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.
Social isolation impairs remyelination in mice through modulation of IL-6.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Two - Dimensional Potentials of Mean Force of Nile Red in Intact and Damaged Model Bilayers. Application to Calculations of Fluorescence Spectra.
Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.
Incidence and Natural History of Idiopathic Chronic Inflammatory Demyelinating Polyneuropathy: A Population-Based Study in Iceland.
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
Pages
« first
‹ previous
…
831
832
833
834
835
836
837
838
839
…
next ›
last »